Djos相关文献与解析，生知库 | 链接生命科学的每一步

Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case report

神经母细胞瘤患者肿瘤和cfDNA全基因组测序的比较分析：病例报告

doi:10.3389/fonc.2025.1569520

Fransson, Susanne; Georgantzi, Kleopatra; Djos, Anna; Gaarder, Jennie; Svensson, Johanna; Anthonydhason, Vimala; Kogner, Per; Martinsson, Tommy; Umapathy, Ganesh

METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma

METTL3 通过 m6A 依赖的 R 环形成驱动 TERRA lncRNA 的端粒靶向：ALT 阳性神经母细胞瘤的治疗靶点

期刊:Nucleic Acids Research

影响因子:16.6

doi:10.1093/nar/gkad1242

Roshan Vaid, Ketan Thombare, Akram Mendez, Rebeca Burgos-Panadero, Anna Djos, Daniel Jachimowicz, Kristina Ihrmark Lundberg, Christoph Bartenhagen, Navinder Kumar, Conny Tümmler, Carina Sihlbom, Susanne Fransson, John Inge Johnsen, Per Kogner, Tommy Martinsson, Matthias Fischer, Tanmoy Mondal

METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma

METTL3/MYCN 协同作用驱动神经嵴分化，并为神经母细胞瘤的治疗提供脆弱性。

期刊:EMBO Journal

影响因子:9.4

doi:10.1038/s44318-024-00299-8

Ketan Thombare #,Roshan Vaid #,Perla Pucci #,Kristina Ihrmark Lundberg,Ritish Ayyalusamy,Mohammad Hassan Baig,Akram Mendez,Rebeca Burgos-Panadero,Stefanie Höppner,Christoph Bartenhagen,Daniel Sjövall,Aqsa Ali Rehan,Sagar Dattatraya Nale,Anna Djos,Tommy Martinsson,Pekka Jaako,Jae-June Dong,Per Kogner,John Inge Johnsen,Matthias Fischer,Suzanne D Turner,Tanmoy Mondal

Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement

神经母细胞瘤中印记基因甲基化改变：对预后改进的意义

期刊:Journal of Translational Medicine

影响因子:7.5

doi:10.1186/s12967-024-05634-5

Suman, Medha; Löfgren, Maja; Fransson, Susanne; Yousuf, Jewahri Idris; Svensson, Johanna; Djos, Anna; Martinsson, Tommy; Kogner, Per; Kling, Teresia; Carén, Helena

Heterogeneous SSTR2 target expression and a novel KIAA1549:: BRAF fusion clone in a progressive metastatic lesion following 177Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report

神经母细胞瘤 177Lutetium-DOTATATE 分子放射治疗后进展性转移性病变中的异质性 SSTR2 靶标表达和新型 KIAA1549:: BRAF 融合克隆：病例报告

期刊:Frontiers in Oncology

影响因子:3.5

doi:10.3389/fonc.2024.1408729

Se Whee Sammy Park, Susanne Fransson, Fredrik Sundquist, Joachim N Nilsson, Per Grybäck, Sandra Wessman, Jacob Strömgren, Anna Djos, Henrik Fagman, Helene Sjögren, Kleopatra Georgantzi, Nikolas Herold, Per Kogner, Dan Granberg, Mark N Gaze, Tommy Martinsson, Kasper Karlsson #, Jakob J E Stenman #

Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

通过循环肿瘤 DNA 分析监测 ALK 驱动的复发或难治性神经母细胞瘤患者对劳拉替尼的长期反应

期刊:Cancer Research Communications

影响因子:2

doi:10.1158/2767-9764.CRC-24-0338

Torben Ek #, Raghda R Ibrahim #, Hartmut Vogt, Kleopatra Georgantzi, Catarina Träger, Jennie Gaarder, Anna Djos, Ida Rahmqvist, Elisabeth Mellström, Fani Pujol-Calderón, Christoffer Vannas, Lina Hansson, Henrik Fagman, Diana Treis, Susanne Fransson, Tobias Österlund, Tzu-Po Chuang, Bronte Manouk Ver

Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma

复发性 3q13.31 染色体重排的鉴定表明 LSAMP 是神经母细胞瘤的肿瘤抑制基因

期刊:International Journal of Oncology

影响因子:4.5

doi:10.3892/ijo.2023.5475

Angela Martinez-Monleon, Jennie Gaarder, Anna Djos, Per Kogner, Susanne Fransson

Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes

一组高风险神经母细胞瘤肿瘤的端粒维持机制及其与 TERT 和 ATRX 基因的基因组变异的关系

期刊:Cancers

影响因子:

doi:10.3390/cancers15245732

Anna Djos, Ketan Thombare, Roshan Vaid, Jennie Gaarder, Ganesh Umapathy, Susanne E Reinsbach, Kleopatra Georgantzi, Jakob Stenman, Helena Carén, Torben Ek, Tanmoy Mondal, Per Kogner, Tommy Martinsson, Susanne Fransson

Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation

一名携带生殖系ALKAL2变异、染色体2p扩增、间变性淋巴瘤激酶和原肌球蛋白受体激酶激活的难治性转移性神经母细胞瘤患儿对恩曲替尼治疗产生持续反应

期刊:Jco Precision Oncology

影响因子:5.6

doi:10.1200/PO.21.00271

Treis, Diana; Umapathy, Ganesh; Fransson, Susanne; Guan, Jikui; Mendoza-García, Patricia; Siaw, Joachim T; Wessman, Sandra; Gordon Murkes, Lena; Stenman, Jakob J E; Djos, Anna; Elfman, Lotta H M; Johnsen, John Inge; Hallberg, Bengt; Palmer, Ruth H; Martinsson, Tommy; Kogner, Per

DNA methylation profiling for molecular classification of neuroblastoma

DNA甲基化谱分析在神经母细胞瘤分子分型中的应用

Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case report

神经母细胞瘤患者肿瘤和cfDNA全基因组测序的比较分析：病例报告

METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma

METTL3 通过 m6A 依赖的 R 环形成驱动 TERRA lncRNA 的端粒靶向：ALT 阳性神经母细胞瘤的治疗靶点

METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma

METTL3/MYCN 协同作用驱动神经嵴分化，并为神经母细胞瘤的治疗提供脆弱性。

Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement

神经母细胞瘤中印记基因甲基化改变：对预后改进的意义

Heterogeneous SSTR2 target expression and a novel KIAA1549:: BRAF fusion clone in a progressive metastatic lesion following 177Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report

神经母细胞瘤 177Lutetium-DOTATATE 分子放射治疗后进展性转移性病变中的异质性 SSTR2 靶标表达和新型 KIAA1549:: BRAF 融合克隆：病例报告

Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

通过循环肿瘤 DNA 分析监测 ALK 驱动的复发或难治性神经母细胞瘤患者对劳拉替尼的长期反应

Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma

复发性 3q13.31 染色体重排的鉴定表明 LSAMP 是神经母细胞瘤的肿瘤抑制基因

Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes

一组高风险神经母细胞瘤肿瘤的端粒维持机制及其与 TERT 和 ATRX 基因的基因组变异的关系

Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation

一名携带生殖系ALKAL2变异、染色体2p扩增、间变性淋巴瘤激酶和原肌球蛋白受体激酶激活的难治性转移性神经母细胞瘤患儿对恩曲替尼治疗产生持续反应